Nurse Practitioner · Miami, FL
NPI
1053069757
Since 2022
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
15794 SW 140th St
Miami, FL, 33196
Phone (786) 387-3126
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,621
66 services
Medicare patients, 2024
45
Average age 74
Drug cost, 2024
$2.5M
656 prescriptions
Company payments, 2025
$579
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana A Romero was code 99214 (office e&m - established), 41 times for 29 patients. In total Diana A Romero billed 66 services in 4 codes, and Medicare paid $4,621.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 41 | 29 | $62.35 | $2,556 |
| 99214 Office E&M - Established | Office | 22 | 17 | $90.94 | $2,001 |
By year: 2023 $2,542 for 39 services; 2024 $4,621 for 66 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diana A Romero prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 57 prescriptions and refills. In total Diana A Romero wrote 656 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 57 | 57 | Under 11 | $981K |
| Ondansetron Hcl Generic | 48 | 48 | 32 | $207 |
| Prochlorperazine Maleate Generic | 45 | 45 | 24 | $398 |
| Levothyroxine Sodium Generic | 41 | 77 | 14 | $165 |
| Eliquis Apixaban | 35 | 51 | 13 | $29K |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $505K |
| Prednisone Generic | 26 | 28 | Under 11 | $52.46 |
| Gilotrif Afatinib Dimaleate | 25 | 25 | Under 11 | $290K |
| Dexamethasone Generic | 24 | 24 | 14 | $188 |
| Hydroxyurea Generic | 21 | 39 | Under 11 | $714 |
| Potassium Chloride Generic | 17 | 38 | Under 11 | $259 |
| Jakafi Ruxolitinib Phosphate | 17 | 17 | Under 11 | $208K |
| Lorazepam Generic | 15 | 15 | 12 | $15.1 |
| Clindamycin Phosphate Generic | 15 | 17 | Under 11 | $674 |
| Cyproheptadine Hcl Generic | 12 | 12 | Under 11 | $34.29 |
Brand drugs: - claims; generic drugs: 436 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana A Romero $579 ($579 in general payments such as food, travel and fees) from 7 companies. The largest payer was Janssen Biotech, Inc. with $235.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.